Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

NCT07570914 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Liver Metastases (CRLM)
Colorectal Cancer
Liver Metastasis

Interventions

DRUG: Liposomal Irinotecan
DRUG: Oxaliplatin
DRUG: Capecitabine
PROCEDURE: hepatic arterial infusion chemotherapy (HAIC)

Sponsor

Tianjin Medical University Cancer Institute and Hospital